WPI 3704 (Armodafinil 200 mg)
Pill imprint WPI 3704 has been identified as Armodafinil 200 mg.
Armodafinil is used in the treatment of obstructive sleep apnea/hypopnea syndrome; narcolepsy; shift work sleep disorder; chronic fatigue syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 3704
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-3704
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
hypromelloses
magnesium stearate
corn starch
More about armodafinil
Consumer resources
- Other brands: Nuvigil
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
